Methyldioxotetrahydropyrimidine sulfonisonikotinoyl hydrazide (Methyldioxotetrahydropyrimidini sulfonisonicotinoyli hydrasidum)

Pharmacodynamics Pharmacokinetics Indications Carefully Contraindications Dosing and Administration Side effects
Read on
Clinical and pharmacological group: & nbsp

Immunomodulators

Included in the formulation
  • Tubosan®
    capsules inwards 
    Biopharm Pravo-Alfa, ZAO     Russia
    • АТХ:

    L.03.A.X   Other immunostimulants

    Pharmacodynamics:

    Immunostimulant, which affects all parts of the immune system. It shows its activity against mycobacteria tuberculosis, leprosy and herpes viruses.

    Pharmacokinetics:

    The maximum concentration is achieved after 9 hours, the therapeutic concentration is maintained for 12-18 hours.

    Indications:

    Diseases on the background of a secondary immunodeficiency state: chlamydia, tuberculosis, leprosy, herpetic infection.

    ICD-10

    I.A70-A74   Other diseases caused by chlamydia

    I.A15-A19   Tuberculosis

    I.A30-A49.A30   Leprosy [Hansen's disease]

    III.D80-D89.D84.9   Immunodeficiency, unspecified

    III.D80-D89.D84.8   Other specified immunodeficiency disorders

    III.D80-D89.D84   Other immunodeficiencies

    Contraindications:

    · Individual intolerance.

    · Pregnancy and breastfeeding.

    Carefully:No data.
    Pregnancy and lactation:The drug is contraindicated during pregnancy and during breastfeeding.
    Dosing and Administration:

    The drug is prescribed for 200-400 mg for 30 minutes before or 2 hours after meals. The maximum daily dose is 1.6 g. In acute diseases, the duration of treatment 2-3 weeks; at chronic - 6-12 months.

    Side effects:

    Allergic reactions.

    Overdose:No data.
    Interaction:

    With simultaneous application increases the effect of antibacterial preparations.

    Special instructions:No data.
    Instructions
    Up